Abolis Biotechnologies: Funding, Investors & Team (Sep 2026)
Abolis is a French company delivering high-impact innovations in biotechnologies that supports industries in their transition to build a better future in collaboration with Nature. We provide tailor-made industrial solutions based on micro-organisms. Founded in 2014, Abolis is made up of a team of over 54 people, sharing a scientific and humanist ambition. Determined to become a key player in the transformation of manufacturing, we combine our expertise in biology, fermentation, IT, robotics, analytics and industrial property to reinvent the future of numerous industries - from food to healthcare, cosmetics and chemicals. We help industries make the ecological transition by rethinking their production models We rely on biotechnologies and the untapped potential of micro-organisms to develop new bioproduction solutions that are economically and ecologically sustainable alternatives to petrochemical products and chemical ingredients. We take up the industry's current challenges by: · Using renewable raw materials · Relocate essential production and secure supply chains · Designing biocompatible products less toxic for the environment · Reducing greenhouse gas emissions Abolis is providing tailor-made industrial solutions, based on microorganisms We are… independent in thought and action rigorous in our approach and the way we work creative because we never stop innovating, while remaining pragmatic ambitious because we are passionate and determined to make a difference
Abolis Biotechnologies has raised $38.6M across 1 funding round on record, the most recent an undisclosed round of $38.6M announced in Sep 2024.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Abolis Biotechnologies Company Profile and Key Stats
Latest funding round on record: Sep 2024.
Abolis Biotechnologies Funding Rounds
Abolis Biotechnologies Founders and Leadership Team
Contact details for the Abolis Biotechnologies team: 1 of 1 has an email address on file.
Start 14-day free trial →Abolis Biotechnologies Funding Compared to Other Biotechnology Startups
Abolis Biotechnologies' latest round of $38.6M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Abolis Biotechnologies in Biotechnology and Évry
Companies Similar to Abolis Biotechnologies
Brenus Pharma is a platform that uses allogeneic techniques to create immune therapy with the goal of…
TISSIUM is a privately owned medical device company based in Paris, France that is dedicated to the rapid…
NicOx is a biopharmaceutical company that focuses on creating and selling nitric oxide-donating drugs for…
Advicenne is a specialty pharmaceutical company dedicated to improving the lives of patients who suffer from…
One Biosciences was founded in Paris, Ile-de-France, France by Magali Richard, David Schilansky, and Céline…
Inventiva Pharma is a biopharmaceutical company in the clinical stage that focuses on creating oral small…
NETRIS Pharma develops therapeutic molecules for treating cancer by targeting dependence receptors for the…
AbIONYX Pharma is a biotechnology company that is focused on providing innovative therapies for indications…
Founded in 2003, Nanobiotix is at the forefront of nanomedicine and is committed to revolutionizing patient…
Theraclion specializes in high-tech medical equipment using high-intensity focused ultrasound (HIFU). They…
Abivax, a clinical stage biotechnology company, is mobilizing the body’s natural immune machinery to treat…
AB Science was established in 2001 by a group of individuals in the medical and business fields who are…
Abolis Biotechnologies Funding FAQs
What does Abolis Biotechnologies do?
Abolis is a French company delivering high-impact innovations in biotechnologies that supports industries in their transition to build a better future in collaboration with Nature. We provide tailor-made industrial solutions based on micro-organisms. Founded in 2014, Abolis is made up of a team of over 54 people, sharing a scientific and humanist ambition. Determined to become a key player in the transformation of manufacturing, we combine our expertise in biology, fermentation, IT, robotics, analytics and industrial property to reinvent the future of numerous industries - from food to healthcare, cosmetics and chemicals. We help industries make the ecological transition by rethinking their production models We rely on biotechnologies and the untapped potential of micro-organisms to develop new bioproduction solutions that are economically and ecologically sustainable alternatives to petrochemical products and chemical ingredients. We take up the industry's current challenges by: · Using renewable raw materials · Relocate essential production and secure supply chains · Designing biocompatible products less toxic for the environment · Reducing greenhouse gas emissions Abolis is providing tailor-made industrial solutions, based on microorganisms We are… independent in thought and action rigorous in our approach and the way we work creative because we never stop innovating, while remaining pragmatic ambitious because we are passionate and determined to make a difference
How much funding has Abolis Biotechnologies raised?
Abolis Biotechnologies has raised $38.6M across 1 round on record. The most recent is an undisclosed round of $38.6M announced in Sep 2024.
When did Abolis Biotechnologies last raise funding?
Abolis Biotechnologies' most recent funding round on record is an undisclosed round of $38.6M, announced in Sep 2024.
Who founded Abolis Biotechnologies?
FundedIQ lists Cyrille Pauthenier (Founder) at Abolis Biotechnologies.
Where is Abolis Biotechnologies headquartered?
Abolis Biotechnologies is based in Évry, Ile-De-France, France.
How many employees does Abolis Biotechnologies have?
Abolis Biotechnologies is in the 51-100 employee band.
How does Abolis Biotechnologies' funding compare to other Biotechnology startups?
Abolis Biotechnologies' latest round of $38.6M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's Abolis Biotechnologies Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Abolis Biotechnologies is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.